Cargando…
Feasibility and Acceptability of Fear-Less: A Stepped-Care Program to Manage Fear of Cancer Recurrence in People with Metastatic Melanoma
Immunotherapies and targeted therapies have revolutionised treatment of metastatic melanoma and improved survival rates. However, survivors treated with novel therapies are vulnerable to high levels of fear of cancer recurrence or progression (FCR). Existing FCR interventions have rarely been triall...
Autores principales: | , , , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7565154/ https://www.ncbi.nlm.nih.gov/pubmed/32937942 http://dx.doi.org/10.3390/jcm9092969 |
_version_ | 1783595873292255232 |
---|---|
author | Lynch, Fiona A Katona, Lynda Jefford, Michael Smith, Allan Ben Shaw, Joanne Dhillon, Haryana M Ellen, Steve Phipps-Nelson, Jo Lai-Kwon, Julia Milne, Donna Russell, Lahiru Dax, Victoria Diggens, Justine Kent, Holly Button-Sloan, Alison Elliott, Jane Shackleton, Mark Burridge, Hayley Ftanou, Maria |
author_facet | Lynch, Fiona A Katona, Lynda Jefford, Michael Smith, Allan Ben Shaw, Joanne Dhillon, Haryana M Ellen, Steve Phipps-Nelson, Jo Lai-Kwon, Julia Milne, Donna Russell, Lahiru Dax, Victoria Diggens, Justine Kent, Holly Button-Sloan, Alison Elliott, Jane Shackleton, Mark Burridge, Hayley Ftanou, Maria |
author_sort | Lynch, Fiona A |
collection | PubMed |
description | Immunotherapies and targeted therapies have revolutionised treatment of metastatic melanoma and improved survival rates. However, survivors treated with novel therapies are vulnerable to high levels of fear of cancer recurrence or progression (FCR). Existing FCR interventions have rarely been trialled in people with advanced cancer. The current study aimed to evaluate the acceptability and feasibility of Fear-Less: a stepped-care model to treat FCR in people with metastatic melanoma treated with immunotherapy or targeted therapy. Sixty-one outpatients with metastatic melanoma were screened using the Fear of Cancer Recurrence Inventory Short Form (FCRI-SF) and Fear of Progression Questionnaire Short Form (FoP-Q-SF). Survivors with subthreshold FCR were stratified to a self-management intervention while those with clinical levels of FCR were provided with an individual therapy, Conquer Fear. Survivor experience surveys and rescreening were administered post-intervention completion. Results indicated that Fear-Less was an acceptable and feasible FCR intervention. Results provided preliminary support for the potential impact of Fear-Less in reducing FCR. Fear-Less is a promising first step in providing an acceptable and feasible stepped-care model to treat FCR in survivors with metastatic disease. |
format | Online Article Text |
id | pubmed-7565154 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-75651542020-10-26 Feasibility and Acceptability of Fear-Less: A Stepped-Care Program to Manage Fear of Cancer Recurrence in People with Metastatic Melanoma Lynch, Fiona A Katona, Lynda Jefford, Michael Smith, Allan Ben Shaw, Joanne Dhillon, Haryana M Ellen, Steve Phipps-Nelson, Jo Lai-Kwon, Julia Milne, Donna Russell, Lahiru Dax, Victoria Diggens, Justine Kent, Holly Button-Sloan, Alison Elliott, Jane Shackleton, Mark Burridge, Hayley Ftanou, Maria J Clin Med Article Immunotherapies and targeted therapies have revolutionised treatment of metastatic melanoma and improved survival rates. However, survivors treated with novel therapies are vulnerable to high levels of fear of cancer recurrence or progression (FCR). Existing FCR interventions have rarely been trialled in people with advanced cancer. The current study aimed to evaluate the acceptability and feasibility of Fear-Less: a stepped-care model to treat FCR in people with metastatic melanoma treated with immunotherapy or targeted therapy. Sixty-one outpatients with metastatic melanoma were screened using the Fear of Cancer Recurrence Inventory Short Form (FCRI-SF) and Fear of Progression Questionnaire Short Form (FoP-Q-SF). Survivors with subthreshold FCR were stratified to a self-management intervention while those with clinical levels of FCR were provided with an individual therapy, Conquer Fear. Survivor experience surveys and rescreening were administered post-intervention completion. Results indicated that Fear-Less was an acceptable and feasible FCR intervention. Results provided preliminary support for the potential impact of Fear-Less in reducing FCR. Fear-Less is a promising first step in providing an acceptable and feasible stepped-care model to treat FCR in survivors with metastatic disease. MDPI 2020-09-14 /pmc/articles/PMC7565154/ /pubmed/32937942 http://dx.doi.org/10.3390/jcm9092969 Text en © 2020 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Lynch, Fiona A Katona, Lynda Jefford, Michael Smith, Allan Ben Shaw, Joanne Dhillon, Haryana M Ellen, Steve Phipps-Nelson, Jo Lai-Kwon, Julia Milne, Donna Russell, Lahiru Dax, Victoria Diggens, Justine Kent, Holly Button-Sloan, Alison Elliott, Jane Shackleton, Mark Burridge, Hayley Ftanou, Maria Feasibility and Acceptability of Fear-Less: A Stepped-Care Program to Manage Fear of Cancer Recurrence in People with Metastatic Melanoma |
title | Feasibility and Acceptability of Fear-Less: A Stepped-Care Program to Manage Fear of Cancer Recurrence in People with Metastatic Melanoma |
title_full | Feasibility and Acceptability of Fear-Less: A Stepped-Care Program to Manage Fear of Cancer Recurrence in People with Metastatic Melanoma |
title_fullStr | Feasibility and Acceptability of Fear-Less: A Stepped-Care Program to Manage Fear of Cancer Recurrence in People with Metastatic Melanoma |
title_full_unstemmed | Feasibility and Acceptability of Fear-Less: A Stepped-Care Program to Manage Fear of Cancer Recurrence in People with Metastatic Melanoma |
title_short | Feasibility and Acceptability of Fear-Less: A Stepped-Care Program to Manage Fear of Cancer Recurrence in People with Metastatic Melanoma |
title_sort | feasibility and acceptability of fear-less: a stepped-care program to manage fear of cancer recurrence in people with metastatic melanoma |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7565154/ https://www.ncbi.nlm.nih.gov/pubmed/32937942 http://dx.doi.org/10.3390/jcm9092969 |
work_keys_str_mv | AT lynchfionaa feasibilityandacceptabilityoffearlessasteppedcareprogramtomanagefearofcancerrecurrenceinpeoplewithmetastaticmelanoma AT katonalynda feasibilityandacceptabilityoffearlessasteppedcareprogramtomanagefearofcancerrecurrenceinpeoplewithmetastaticmelanoma AT jeffordmichael feasibilityandacceptabilityoffearlessasteppedcareprogramtomanagefearofcancerrecurrenceinpeoplewithmetastaticmelanoma AT smithallanben feasibilityandacceptabilityoffearlessasteppedcareprogramtomanagefearofcancerrecurrenceinpeoplewithmetastaticmelanoma AT shawjoanne feasibilityandacceptabilityoffearlessasteppedcareprogramtomanagefearofcancerrecurrenceinpeoplewithmetastaticmelanoma AT dhillonharyanam feasibilityandacceptabilityoffearlessasteppedcareprogramtomanagefearofcancerrecurrenceinpeoplewithmetastaticmelanoma AT ellensteve feasibilityandacceptabilityoffearlessasteppedcareprogramtomanagefearofcancerrecurrenceinpeoplewithmetastaticmelanoma AT phippsnelsonjo feasibilityandacceptabilityoffearlessasteppedcareprogramtomanagefearofcancerrecurrenceinpeoplewithmetastaticmelanoma AT laikwonjulia feasibilityandacceptabilityoffearlessasteppedcareprogramtomanagefearofcancerrecurrenceinpeoplewithmetastaticmelanoma AT milnedonna feasibilityandacceptabilityoffearlessasteppedcareprogramtomanagefearofcancerrecurrenceinpeoplewithmetastaticmelanoma AT russelllahiru feasibilityandacceptabilityoffearlessasteppedcareprogramtomanagefearofcancerrecurrenceinpeoplewithmetastaticmelanoma AT daxvictoria feasibilityandacceptabilityoffearlessasteppedcareprogramtomanagefearofcancerrecurrenceinpeoplewithmetastaticmelanoma AT diggensjustine feasibilityandacceptabilityoffearlessasteppedcareprogramtomanagefearofcancerrecurrenceinpeoplewithmetastaticmelanoma AT kentholly feasibilityandacceptabilityoffearlessasteppedcareprogramtomanagefearofcancerrecurrenceinpeoplewithmetastaticmelanoma AT buttonsloanalison feasibilityandacceptabilityoffearlessasteppedcareprogramtomanagefearofcancerrecurrenceinpeoplewithmetastaticmelanoma AT elliottjane feasibilityandacceptabilityoffearlessasteppedcareprogramtomanagefearofcancerrecurrenceinpeoplewithmetastaticmelanoma AT shackletonmark feasibilityandacceptabilityoffearlessasteppedcareprogramtomanagefearofcancerrecurrenceinpeoplewithmetastaticmelanoma AT burridgehayley feasibilityandacceptabilityoffearlessasteppedcareprogramtomanagefearofcancerrecurrenceinpeoplewithmetastaticmelanoma AT ftanoumaria feasibilityandacceptabilityoffearlessasteppedcareprogramtomanagefearofcancerrecurrenceinpeoplewithmetastaticmelanoma |